Michael Sison's questions to International Flavors & Fragrances Inc (IFF) leadership • Q2 2025
Question
Michael Sison pointed out the implied 10% sequential decline in ex-Pharma EBITDA from H1 to H2 and asked if this was due to normal seasonality or incremental consumer slowing.
Answer
CFO Michael Deveau confirmed that a sequential step-down is expected. He attributed it partly to normal business seasonality, as Q4 is historically the lowest margin quarter of the year. He also acknowledged that the decline reflects the previously discussed softening in volume performance expected in the second half.